Pneumococcal Vaccines Market Progress Strategy, Survey, Opportunities and Forecast to 2025

Page 1

Pneumococcal Vaccines Market Progress Strategy, Survey, Opportunities and Forecast to 2025 Market Analysis and Insights: Pneumococcal vaccine market is expected to gain market growth in the forecast period of 2020 to 2025.QandQ Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Rising prevalence of the disease, growing awareness and development of newer therapies with minimum invasive nature are the factors responsible for the growth of this market The major players covered in the pneumococcal vaccine market are GlaxoSmithKline, Plc., Sanofi, Merck & Co., Inc., Panacea Biotec Ltd, Pfizer Inc, PnuVax Incorporated, SK bioscience, Walvax Biotechnology Co., Ltd, Beijing Minhai Biotechnology Co.,Ltd and among others. Click the to download the PDF Sample of this report@ https://www.qandqmarketresearch.com/report-sample/579096

Vaccination is one of the most cost-effective and safest ways to prevent diseases. Pneumococcus is one of the major causes of blood infection, pneumonia, sinusitis, meningitis, and otitis media. It is also a leading infectious disease. However, it can be prevented with the help of vaccination. Majority of countries have pneumococcal vaccines in their national immunization program for children aged under 1 year. Increase in pneumococcal diseases due to causative serotype drives the need for vaccines with broader coverage. Hence, demand for new pneumococcal vaccines with wider serotype coverage is rising. Market Segment by Product Type PPSV 23 PCV 7/13 PCV 10

Market Segment by Application For Infants For Children 2-10


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.